Not_yet_recruitingNCT07590271

Research on the Whole Process of AI Intelligent Management System for the Diagnosis and Treatment of Inflammatory Bowel Diseases

Sponsor: Taichung Veterans General Hospital

Trial Details

Condition	Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Crohn's Disease (CD), Ulcerative Colitis (UC), Artificial Intelligence (AI), Natural Language Processing (NLP)
Status	Not_yet_recruiting
Participants	4,500
Est. Completion	1 Dec 2027
Last Updated	15 May 2026

Primary Outcome

developing localized AI models for IBD

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: Inclusion criteria for the IBD group: Patients diagnosed with IBD (K50.00 to K51.919) within the specified time interval. Inclusion criteria for the non-IBD group: Patients never diagnosed with IBD (K50.00 to K51.919) within the specified time interval. Exclusion Criteria: Patients not within the specified time interval Deceased patients Exclusion criteria for the non-IBD group: Patients not within the specified time interval Deceased patients Patients with fewer than 5 hospital visits

Trial Sites

Countries

Taiwan

View Registry Entry

Related Analysis

Taiwanese AI Study Aims to Transform IBD Diagnosis: 4,500-Patient Retrospective Analysis of Machine Learning in Crohn's and Ulcerative Colitis Detection

Taiwanese researchers are developing AI models to improve IBD diagnosis using electronic medical records from 4,500 patients. The study could transform early detection of Crohn's disease and ulcerative colitis.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service